https://massachusettsweekly.com/article/912321406-cfo-leadership-launches-cfo-bootcamp-an-executive-program-to-transform-finance-leaders-into-enterprise-architects Massachusetts Weekly en PressRelease 2026-05-14T14:15:00+00:00 CFO Leadership Launches 'CFO Bootcamp,' an Executive Program to Transform Finance Leaders into Enterprise Architects https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24854710-cfo-bootcamp-gen-2295x2869.png https://massachusettsweekly.com/article/912557138-millstone-medical-launches-self-serve-lab-quote-builder-with-published-turnaround-times-four-hour-response-commitment Massachusetts Weekly en PressRelease 2026-05-14T12:45:00+00:00 Millstone Medical Launches Self-Serve Lab Quote Builder with Published Turnaround Times & Four-Hour Response Commitment https://massachusettsweekly.com/article/912017685-tellubase-h1-2026-semi-annual-edition-now-released-by-tellusant Massachusetts Weekly en PressRelease 2026-05-14T12:30:00+00:00 TelluBase H1 2026 Semi-Annual Edition Now Released by Tellusant https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24855746-shane-ezepik-1312x1055.jpeg https://massachusettsweekly.com/article/912885597-flywire-to-attend-upcoming-investor-conferences Massachusetts Weekly en PressRelease 2026-05-14T21:25:20+00:00 Flywire to Attend Upcoming Investor Conferences https://ml.globenewswire.com/media/9b1123f3-5f90-4036-ab7b-c4c3d1f5491b/small/flywire-logo-jpg.jpg https://massachusettsweekly.com/article/912885103-aspen-aerogels-begins-staged-restart-of-east-providence-facility Massachusetts Weekly en PressRelease 2026-05-14T20:30:00+00:00 Aspen Aerogels Begins Staged Restart of East Providence Facility https://ml.globenewswire.com/media/d9832b9e-3339-4760-9351-f988900fc3b9/small/aspn-logo-jpg.jpg https://massachusettsweekly.com/article/912865161-cue-biopharma-reports-first-quarter-2026-financial-results-and-recent-strategic-developments Massachusetts Weekly en PressRelease 2026-05-14T20:07:28+00:00 Cue Biopharma Reports First Quarter 2026 Financial Results and Recent Strategic Developments https://ml.globenewswire.com/media/10541379-34cc-4869-a26f-fd99feead42a/small/cue-bio-brand-strategy-graphics-jpg.jpg https://massachusettsweekly.com/article/912844455-tive-reaches-100-million-in-booked-arr Massachusetts Weekly en PressRelease 2026-05-14T17:06:35+00:00 Tive Reaches $100 Million in Booked ARR https://ml.globenewswire.com/media/6f1b8681-efee-4d3f-8837-8e34b54e3fbe/small/tivelogo-jpg.jpg https://massachusettsweekly.com/article/912671427-lowell-summer-music-series-announces-full-lineup-for-36th-season Massachusetts Weekly en PressRelease 2026-05-14T04:52:54+00:00 Lowell Summer Music Series Announces Full Lineup for 36th Season https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24856307-lowell-logo-400x187.png https://massachusettsweekly.com/article/912825447-tecomet-and-orchid-complete-transaction-creating-a-scaled-global-manufacturing-platform Massachusetts Weekly en PressRelease 2026-05-14T16:00:00+00:00 Tecomet and Orchid Complete Transaction, Creating a Scaled Global Manufacturing Platform https://ml.globenewswire.com/media/ZTdkZGI5NjAtMTAyNS00ZTk3LTg2NjgtM2I4Y2IyNGJiNTUxLTUwMDE1NzE3MC0yMDI2LTA1LTE0LWVu/tiny/Tecomet.png https://massachusettsweekly.com/article/912825550-imviva-biotech-presents-data-demonstrating-durable-clinical-responses-from-ongoing-phase-1-2-study-of-cta313-in-systemic-lupus-erythematosus-at-asgct Massachusetts Weekly en PressRelease 2026-05-14T15:43:11+00:00 Imviva Biotech Presents Data Demonstrating Durable Clinical Responses from Ongoing Phase 1/2 Study of CTA313 in Systemic Lupus Erythematosus at ASGCT 2026 https://ml.globenewswire.com/media/YTAyNGM0NGQtNjE0YS00ZmY2LTgxZTktNWRjZjY3M2QzZDM4LTEzMTkxMjUtMjAyNi0wNS0xNC1lbg==/tiny/Imviva-US-Holdings-LLC.png https://massachusettsweekly.com/article/912825544-zapata-quantum-to-present-alongside-fortune-500-and-quantum-leaders-at-upcoming-investor-and-industry-conferences Massachusetts Weekly en PressRelease 2026-05-14T15:40:56+00:00 Zapata Quantum to Present Alongside Fortune 500 and Quantum Leaders at Upcoming Investor and Industry Conferences https://ml.globenewswire.com/media/56af279d-d179-411c-82ab-b1ba4f7f9b20/small/blank-logo-jpg.jpg https://massachusettsweekly.com/article/912825451-ai-technology-investment-surges-to-297-billion-globally-as-enterprise-deployment-accelerates-toward-production-scale Massachusetts Weekly en PressRelease 2026-05-14T15:18:59+00:00 AI Technology Investment Surges to $297 Billion Globally as Enterprise Deployment Accelerates Toward Production Scale https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png https://massachusettsweekly.com/article/912807389-tessera-therapeutics-showcases-new-preclinical-data-advancing-in-vivo-program-in-sickle-cell-disease-and-car-t-applications-at-the-american-society-of Massachusetts Weekly en PressRelease 2026-05-14T14:20:08+00:00 Tessera Therapeutics Showcases New Preclinical Data Advancing In Vivo Program in Sickle Cell Disease and CAR-T Applications at the American Society of Gene and Cell Therapy 29th Annual Meeting https://ml.globenewswire.com/media/f24875fb-efec-43e6-8b98-2da3edea398a/small/picture1-jpg.jpg https://massachusettsweekly.com/article/912806237-heilind-electronics-expands-circuit-protection-portfolio-with-optifuse-partnership Massachusetts Weekly en PressRelease 2026-05-14T14:00:00+00:00 Heilind Electronics Expands Circuit Protection Portfolio with OptiFuse Partnership https://ml.globenewswire.com/media/dbd794ad-7ff1-4038-b1e7-d57ced923a83/medium/optifuse.jpg https://massachusettsweekly.com/article/912806032-progress-agentic-rag-named-2026-ai-excellence-award-winner-for-advancing-retrieval-augmented-generation Massachusetts Weekly en PressRelease 2026-05-14T13:00:00+00:00 Progress Agentic RAG Named 2026 AI Excellence Award Winner for Advancing Retrieval-Augmented Generation https://ml.globenewswire.com/media/2a4a917f-af24-458f-b64e-25e5e5cc6c26/small/progress-logo-jpg.jpg https://massachusettsweekly.com/article/912806240-omg-issues-rfp-for-tacsit-configuration-settings-and-services Massachusetts Weekly en PressRelease 2026-05-14T13:00:00+00:00 OMG Issues RFP for TACSIT Configuration Settings and Services https://ml.globenewswire.com/media/OTg1MjlkM2MtNjI3Ni00MzQ3LWIzYmUtMGIwZDVjNmI2NTkxLTEyNjQwNDItMjAyNi0wNS0xNC1lbg==/tiny/Object-Management-Group-SDO.png https://massachusettsweekly.com/article/912806366-cj-biomaterials-launches-new-home-compostable-all-pha-extrusion-coating-resin-for-paper-food-serviceware Massachusetts Weekly en PressRelease 2026-05-14T13:00:00+00:00 CJ Biomaterials Launches New Home Compostable all-PHA Extrusion Coating Resin for Paper Food Serviceware https://ml.globenewswire.com/media/5dbaaccd-ff7a-4d66-8c07-19059a6bd89e/medium/compostable-coffee-cup.jpg https://massachusettsweekly.com/article/912806984-biogen-completes-acquisition-of-apellis-pharmaceuticals Massachusetts Weekly en PressRelease 2026-05-14T12:35:00+00:00 Biogen Completes Acquisition of Apellis Pharmaceuticals https://ml.globenewswire.com/media/80f9c524-3da2-4583-a763-0dad931fa182/small/biogen-logo-standard-rgb-r-jpg.jpg https://massachusettsweekly.com/article/912787448-microbot-medical-successfully-transitions-to-commercial-operations-as-it-records-revenue-resulting-from-its-limited-market-release-during-the-first Massachusetts Weekly en PressRelease 2026-05-14T12:30:00+00:00 Microbot Medical Successfully Transitions to Commercial Operations as It Records Revenue Resulting from Its Limited Market Release During the First Quarter of 2026 https://ml.globenewswire.com/media/346df7fb-c134-40c2-970a-39bcbaf974cd/small/mbot-logo-rgb-jpg.jpg https://massachusettsweekly.com/article/912787541-hycu-wakes-up-backup-with-air-launch-adds-new-ai-capabilities-across-protected-systems-of-record-within-its-market-leading-r-cloud-resilience Massachusetts Weekly en PressRelease 2026-05-14T12:30:00+00:00 HYCU® Wakes up Backup with aiR™; Launch Adds New AI Capabilities Across Protected Systems of Record Within Its Market-leading R-Cloud Resilience Platform https://ml.globenewswire.com/media/OTk3OTA3NDMtZDYxMC00NGY1LWJlMGYtMDQ0M2M0NGFkZjQyLTEyMDU5NTEtMjAyNi0wNS0xNC1lbg==/tiny/HYCU-Inc-.png https://massachusettsweekly.com/article/912788087-vor-bio-announces-publication-of-interim-analysis-of-teligan-a-china-phase-3-trial-of-telitacicept-in-iga-nephropathy-in-the-new-england-journal-of Massachusetts Weekly en PressRelease 2026-05-14T12:30:00+00:00 Vor Bio Announces Publication of Interim Analysis of TELIGAN, a China Phase 3 Trial of Telitacicept in IgA Nephropathy, in The New England Journal of Medicine https://ml.globenewswire.com/media/dde67700-b1b4-40c4-b930-13bd71804762/small/vor-wordmark-rgb-fullcolor-070920-png.png https://massachusettsweekly.com/article/912786615-candel-therapeutics-reports-first-quarter-2026-financial-results-and-recent-corporate-highlights Massachusetts Weekly en PressRelease 2026-05-14T12:05:00+00:00 Candel Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights https://ml.globenewswire.com/media/8b82e1e3-4a67-4472-a7c8-05f9d24c9bb0/small/candel-logo-fullcolor-4-png.png https://massachusettsweekly.com/article/912786697-keros-therapeutics-reports-recent-first-quarter-2026-financial-results Massachusetts Weekly en PressRelease 2026-05-14T12:00:00+00:00 Keros Therapeutics Reports Recent First Quarter 2026 Financial Results https://ml.globenewswire.com/media/baf5be5e-8ec5-4b74-8950-e28c4888b29c/small/keros-2-jpg.jpg https://massachusettsweekly.com/article/912786788-acquia-launches-fair-trade-initiative-committing-2-of-every-eligible-partner-deal-to-the-drupal-association Massachusetts Weekly en PressRelease 2026-05-14T12:00:00+00:00 Acquia Launches Fair Trade Initiative, Committing 2% of Every Eligible Partner Deal to the Drupal Association https://ml.globenewswire.com/media/b7cbd5b8-edd2-4291-bbf6-306a92ed650f/small/acquia-logo-png.png https://massachusettsweekly.com/article/912787373-corbus-pharmaceuticals-appoints-pharma-industry-veteran-brent-pfeiffenberger-to-board-of-directors Massachusetts Weekly en PressRelease 2026-05-14T12:00:00+00:00 Corbus Pharmaceuticals Appoints Pharma Industry Veteran Brent Pfeiffenberger to Board of Directors https://ml.globenewswire.com/media/459d6fb1-b336-4d47-8aa1-f9198bda891d/small/corbus-logo-jpg.jpg https://massachusettsweekly.com/article/912787785-acronis-appoints-jim-tedesco-as-chief-revenue-officer Massachusetts Weekly en PressRelease 2026-05-14T12:00:00+00:00 Acronis Appoints Jim Tedesco as Chief Revenue Officer https://ml.globenewswire.com/media/2d47defd-3e29-47ba-90cd-3bb23a9d1938/medium/acronis-appoints-jim-tedesco-as-chief-revenue-officer.png https://massachusettsweekly.com/article/912788127-merlin-unveils-plans-for-ai-powered-autonomy-for-commercial-cargo-aircraft Massachusetts Weekly en PressRelease 2026-05-14T12:00:00+00:00 Merlin Unveils Plans for AI-Powered Autonomy for Commercial Cargo Aircraft https://ml.globenewswire.com/media/30f04298-e7db-4dfa-9a1e-8c6452cdfce0/small/merlin-logo-jpg.jpg https://massachusettsweekly.com/article/912787101-elevatebio-data-at-asgct-29th-annual-meeting-showcase-expanded-gene-editing-platform-and-services-spanning-new-modalities-ai-discovery-and-lnp Massachusetts Weekly en PressRelease 2026-05-14T11:30:00+00:00 ElevateBio Data at ASGCT 29th Annual Meeting Showcase Expanded Gene Editing Platform and Services Spanning New Modalities, AI Discovery, and LNP Delivery https://ml.globenewswire.com/media/42238eb2-fd1c-4189-bf14-c7026687de5b/small/elevatebiologo-jpg.jpg https://massachusettsweekly.com/article/912787848-merlin-inc-reports-first-quarter-2026-results Massachusetts Weekly en PressRelease 2026-05-14T11:30:00+00:00 Merlin, Inc. Reports First Quarter 2026 Results https://ml.globenewswire.com/media/30f04298-e7db-4dfa-9a1e-8c6452cdfce0/small/merlin-logo-jpg.jpg https://massachusettsweekly.com/article/912786644-eyepoint-announces-third-consecutive-positive-dsmc-recommendation-for-phase-3-wet-amd-trials-for-duravyu-building-confidence-ahead-of-mid-2026 Massachusetts Weekly en PressRelease 2026-05-14T11:00:00+00:00 EyePoint Announces Third Consecutive Positive DSMC Recommendation for Phase 3 Wet AMD Trials for DURAVYU™, Building Confidence Ahead of Mid-2026 Topline Data https://ml.globenewswire.com/media/3934240c-3155-4c7d-a525-885791fdab8b/small/eypoint-new-reg-vertical-3c-rgb1-jpg.jpg https://massachusettsweekly.com/article/912786712-destination-xl-group-inc-to-announce-first-quarter-2026-financial-results-on-thursday-may-28-2026 Massachusetts Weekly en PressRelease 2026-05-14T11:00:00+00:00 Destination XL Group, Inc. to Announce First Quarter 2026 Financial Results on Thursday, May 28, 2026 https://ml.globenewswire.com/media/6ecdc08b-a991-4864-bec7-55382a7936d8/small/dxl-b-t-2020-jpg.jpg https://massachusettsweekly.com/article/912787126-climb-bio-to-present-new-budoprutug-clinical-data-at-european-hematology-association-eha-2026-congress Massachusetts Weekly en PressRelease 2026-05-14T11:00:00+00:00 Climb Bio to Present New Budoprutug Clinical Data at European Hematology Association (EHA) 2026 Congress https://ml.globenewswire.com/media/2a42b557-6e44-4818-bfce-2238a05f2c43/small/climb-400x400-002-jpg.jpg https://massachusettsweekly.com/article/912787191-pyxis-oncology-reports-first-quarter-2026-financial-results-and-advances-micvo-toward-key-2026-clinical-milestones Massachusetts Weekly en PressRelease 2026-05-14T11:00:00+00:00 Pyxis Oncology Reports First Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones https://ml.globenewswire.com/media/d3b77f06-3f52-42af-8f38-e3fda9c8025b/small/pyxis-logo-jpg.jpg https://massachusettsweekly.com/article/912787640-akamai-technologies-announces-intent-to-acquire-layerx-advancing-its-workforce-security-strategy-with-ai-usage-control Massachusetts Weekly en PressRelease 2026-05-14T11:00:00+00:00 Akamai Technologies Announces Intent to Acquire LayerX, Advancing Its Workforce Security Strategy with AI Usage Control https://ml.globenewswire.com/media/4ce7685a-3da0-416d-9bc1-58cc8b7812b8/small/akamai-logo-color-rgb-bluenavy-png.png https://massachusettsweekly.com/article/912787739-camp4-therapeutics-to-present-new-preclinical-data-demonstrating-cmp-002-improves-seizure-threshold-and-severity-in-a-model-of-syngap1-related Massachusetts Weekly en PressRelease 2026-05-14T11:00:00+00:00 CAMP4 Therapeutics to Present New Preclinical Data Demonstrating CMP-002 Improves Seizure Threshold and Severity in a Model of SYNGAP1-Related Disorder https://ml.globenewswire.com/media/72048fc6-0a8d-4ed2-9be8-ec0ee0afd8ba/small/cmp4-21-logo-full-color-jpg.jpg https://massachusettsweekly.com/article/912787248-topline-results-from-phase-2-celia-study-of-diranersen-biib080-first-study-to-show-reduction-in-tau-pathology-and-cognitive-benefit-in-patients Massachusetts Weekly en PressRelease 2026-05-14T10:59:00+00:00 Topline Results from Phase 2 CELIA Study of Diranersen (BIIB080): First Study to Show Reduction in Tau Pathology and Cognitive Benefit in Patients with Early Alzheimer’s Disease https://ml.globenewswire.com/media/80f9c524-3da2-4583-a763-0dad931fa182/small/biogen-logo-standard-rgb-r-jpg.jpg https://massachusettsweekly.com/article/912767795-editas-medicine-reports-new-preclinical-data-demonstrating-progress-of-edit-401-as-potential-treatment-for-hyperlipidemia-at-the-american-society-of Massachusetts Weekly en PressRelease 2026-05-14T10:01:00+00:00 Editas Medicine Reports New Preclinical Data Demonstrating Progress of EDIT-401 as Potential Treatment for Hyperlipidemia at the American Society of Gene and Cell Therapy 2026 Annual Meeting https://ml.globenewswire.com/media/03686b66-5cbc-40b5-9dfa-be0e7858ac97/small/editas-logo-small-1-jpg.jpg https://massachusettsweekly.com/article/912600869-health-imperatives-announces-upcoming-leadership-changes Massachusetts Weekly en PressRelease 2026-05-13T20:39:12+00:00 Health Imperatives Announces Upcoming Leadership Changes https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24856039-julia-kehoe-and-stephanie-brown-1920x800.png https://massachusettsweekly.com/article/912057328-efcg-and-msa-professional-services-launch-imeritus-pilot-to-transform-institutional-knowledge-into-a-capital-asset Massachusetts Weekly en PressRelease 2026-05-13T20:35:38+00:00 EFCG and MSA Professional Services Launch IMERITUS Pilot to Transform Institutional Knowledge into a Capital Asset https://massachusettsweekly.com/article/912559091-peloton-consulting-announces-strategic-investment-from-sunstone-partners-to-accelerate-ai-enabled-innovation-and-growth Massachusetts Weekly en PressRelease 2026-05-13T19:27:45+00:00 Peloton Consulting Announces Strategic Investment from Sunstone Partners to Accelerate AI Enabled Innovation and Growth https://massachusettsweekly.com/article/912578609-ballers-seaport-announces-grand-opening-weekend-celebration-featuring-fitness-classes-challenges-cold-plunges-more Massachusetts Weekly en PressRelease 2026-05-13T18:41:40+00:00 Ballers Seaport Announces Grand Opening Weekend Celebration Featuring Fitness Classes, Challenges, Cold Plunges & More https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24833517-ballers-seaport-aerial-1206x898.jpeg https://massachusettsweekly.com/article/912029187-study-9-in-10-college-students-want-to-debate-but-66-stay-silent Massachusetts Weekly en PressRelease 2026-05-13T13:30:00+00:00 Study: 9 in 10 College Students Want to Debate — but 66% Stay Silent https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24854788-banjo-discourse-divide-infogr-2400x1256.jpeg https://massachusettsweekly.com/article/912458959-beyond-the-click-onescreen-s-68-q1-surge-signals-a-new-era-of-high-confidence-marketing-in-the-real-world Massachusetts Weekly en PressRelease 2026-05-13T13:00:00+00:00 Beyond the Click: Onescreen's 68% Q1 Surge Signals a New Era of High-Confidence Marketing in the Real World https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24855297-os-logo-2227x241.png https://massachusettsweekly.com/article/912295653-massachusetts-schools-can-now-use-state-grant-funding-for-bell-to-bell-phone-storage-solutions Massachusetts Weekly en PressRelease 2026-05-13T12:31:10+00:00 Massachusetts Schools Can Now Use State Grant Funding for Bell-to-Bell Phone Storage Solutions https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24630407-nukase-logo2-800x313.png https://massachusettsweekly.com/article/912315675-lydonia-sponsors-automation-anywhere-imagine-2026-conference-advancing-focus-on-ai-value Massachusetts Weekly en PressRelease 2026-05-13T12:00:00+00:00 Lydonia Sponsors Automation Anywhere Imagine 2026 Conference, Advancing Focus on AI Value https://massachusettsweekly.com/article/912275488-violet-therapeutics-raises-4-75m-seed-extension-to-advance-novel-therapeutic-for-synaptic-preservation-and-repair Massachusetts Weekly en PressRelease 2026-05-13T09:00:00+00:00 Violet Therapeutics Raises $4.75M Seed Extension to Advance Novel Therapeutic for Synaptic Preservation and Repair https://massachusettsweekly.com/article/912629494-marimed-reports-first-quarter-2026-earnings Massachusetts Weekly en PressRelease 2026-05-13T21:00:00+00:00 MariMed Reports First Quarter 2026 Earnings https://ml.globenewswire.com/media/d78e59da-6797-4331-81fb-187d81a70f06/small/mrmd-logo-png.png https://massachusettsweekly.com/article/912602850-precision-optics-reports-third-quarter-fiscal-year-2026-financial-results Massachusetts Weekly en PressRelease 2026-05-13T20:30:00+00:00 Precision Optics Reports Third Quarter Fiscal Year 2026 Financial Results https://ml.globenewswire.com/media/6d86ce33-7e41-41e5-90b0-1c74cd89785e/small/precision-optics-logo-jpg.jpg https://massachusettsweekly.com/article/912603349-rapid-micro-biosystems-reports-first-quarter-2026-financial-results Massachusetts Weekly en PressRelease 2026-05-13T20:25:58+00:00 Rapid Micro Biosystems Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/12585575-0b2e-4369-bf15-500b17ccb859/small/rapid-micro-biosystems-logo.png https://massachusettsweekly.com/article/912602856-acrivon-reports-first-quarter-2026-financial-results-and-highlights-progress-towards-key-2026-clinical-catalysts Massachusetts Weekly en PressRelease 2026-05-13T20:10:00+00:00 Acrivon Reports First Quarter 2026 Financial Results and Highlights Progress Towards Key 2026 Clinical Catalysts https://ml.globenewswire.com/media/7935747b-f8f5-48e8-b925-6935300d63e5/small/acrivon-logo-jpg.jpg https://massachusettsweekly.com/article/912603310-tango-therapeutics-reports-first-quarter-2026-financial-results-and-provides-business-highlights Massachusetts Weekly en PressRelease 2026-05-13T20:07:25+00:00 Tango Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights https://ml.globenewswire.com/media/d6e37a27-2e33-43bb-ae05-bfb0dedbf190/small/tango-logo-png.png https://massachusettsweekly.com/article/912602348-spero-therapeutics-announces-first-quarter-2026-operating-results-and-provides-business-update Massachusetts Weekly en PressRelease 2026-05-13T20:05:00+00:00 Spero Therapeutics Announces First Quarter 2026 Operating Results and Provides Business Update https://ml.globenewswire.com/media/aad6f25c-1793-4870-a611-84ea3f25fed3/small/spero-logo-jpg.jpg https://massachusettsweekly.com/article/912602376-wave-life-sciences-to-present-at-2026-rbc-capital-markets-global-healthcare-conference Massachusetts Weekly en PressRelease 2026-05-13T20:05:00+00:00 Wave Life Sciences to Present at 2026 RBC Capital Markets Global Healthcare Conference https://ml.globenewswire.com/media/b2c5e218-8ae8-4dc2-b6f2-cf55b6b3b6e0/small/wave-life-sciences-logo-jpg.jpg https://massachusettsweekly.com/article/912578647-the-sewerage-and-water-board-of-new-orleans-selects-cdm-smith-to-manage-1-billion-lead-line-replacement-program Massachusetts Weekly en PressRelease 2026-05-13T18:00:00+00:00 The Sewerage and Water Board of New Orleans selects CDM Smith to manage $1 billion lead line replacement program https://ml.globenewswire.com/media/YjNlODY1MTMtOTI0OS00NmQ2LTliZGUtNDQ0YzM2ZThjYTI2LTEyNDUwODEtMjAyNi0wNS0xMy1lbg==/tiny/CDM-Smith.png https://massachusettsweekly.com/article/912533857-ai-powered-plastics-recycling-gains-momentum-as-investment-surges-and-technology-delivers-measurable-roi Massachusetts Weekly en PressRelease 2026-05-13T14:09:12+00:00 AI-Powered Plastics Recycling Gains Momentum as Investment Surges and Technology Delivers Measurable ROI https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png https://massachusettsweekly.com/article/912533560-quickbase-expands-real-time-ai-capabilities-for-field-service-teams Massachusetts Weekly en PressRelease 2026-05-13T14:00:00+00:00 Quickbase Expands Real-Time AI Capabilities for Field Service Teams  https://ml.globenewswire.com/media/348bbc98-87d0-4dbd-8ee3-749e93775583/small/quickbase-logo-fullcolor-dune-png.png https://massachusettsweekly.com/article/912532771-ip-fabric-expands-netbox-integration-to-deliver-continuous-network-validation-for-enterprise-operations Massachusetts Weekly en PressRelease 2026-05-13T13:04:00+00:00 IP Fabric Expands NetBox Integration to Deliver Continuous Network Validation for Enterprise Operations https://ml.globenewswire.com/media/097f9a64-fb8d-41a9-bb00-70f61fc84bdd/medium/network-automation-ecosystem.png https://massachusettsweekly.com/article/912532870-wolf-company-p-c-continues-national-expansion-with-presence-in-florida-and-texas Massachusetts Weekly en PressRelease 2026-05-13T13:00:00+00:00 Wolf & Company, P.C. Continues National Expansion With Presence In Florida And Texas https://ml.globenewswire.com/media/YjFhYmE3ZDktN2ExNi00NDhmLTkxNTMtNTQ2MDFiNGU0MmY5LTUwMDE1ODI3NC0yMDI2LTA1LTEzLWVu/tiny/Wolf-Company-P-C-.png https://massachusettsweekly.com/article/912533182-vicarious-surgical-demonstrates-sustained-system-performance-and-complex-hernia-procedure-workflows-in-pre-clinical-setting Massachusetts Weekly en PressRelease 2026-05-13T13:00:00+00:00 Vicarious Surgical Demonstrates Sustained System Performance and Complex Hernia Procedure Workflows in Pre-Clinical Setting https://ml.globenewswire.com/media/MzM2MmFiNjItZDU1Yi00MTdiLTkyYTctNTk1ZmMxODcwNjYwLTEyMTM5OTQtMjAyNi0wNS0xMy1lbg==/tiny/Vicarious-Surgical.png https://massachusettsweekly.com/article/912532630-aware-announces-successful-independent-evaluation-of-intelligent-liveness-aligned-with-cen-ts-18099 Massachusetts Weekly en PressRelease 2026-05-13T12:30:00+00:00 Aware Announces Successful Independent Evaluation of Intelligent Liveness Aligned with CEN/TS 18099 https://ml.globenewswire.com/media/a04f465c-3b1c-4f2a-a547-3fcb543ddaa2/small/aware-logo-for-press-releases-jpg.jpg https://massachusettsweekly.com/article/912532659-bicara-therapeutics-announces-inducement-grant-under-nasdaq-listing-rule-5635-c-4 Massachusetts Weekly en PressRelease 2026-05-13T12:30:00+00:00 Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/fdf5e06f-0748-428a-8f90-b0a1c6f7bdf3/small/bicara-logo-struck-png.png https://massachusettsweekly.com/article/912532759-rectify-pharmaceuticals-to-present-preclinical-data-on-new-dual-targeted-abcb4-bsep-positive-functional-modulator-at-easl-2026 Massachusetts Weekly en PressRelease 2026-05-13T12:30:00+00:00 Rectify Pharmaceuticals to Present Preclinical Data on New Dual Targeted ABCB4/BSEP Positive Functional Modulator at EASL 2026 https://ml.globenewswire.com/media/bdac6aa0-18b4-4330-98a1-e9673a671b69/small/rectify-logo-color-jpg.jpg https://massachusettsweekly.com/article/912532964-nha-s-2026-industry-outlook-highlights-growing-need-for-allied-health-professionals-and-the-rising-value-of-certification Massachusetts Weekly en PressRelease 2026-05-13T12:30:00+00:00 NHA’s 2026 Industry Outlook Highlights Growing Need for Allied Health Professionals and the Rising Value of Certification https://ml.globenewswire.com/media/MzAyYWQyYzEtZjgzYS00N2M0LWExZjMtNjI1MjRlNjJmN2YwLTEyMDA5MjYtMjAyNi0wNS0xMy1lbg==/tiny/Ascend-Learning-Inc-.png https://massachusettsweekly.com/article/912533320-vor-bio-reports-first-quarter-2026-financial-results-and-provides-corporate-update Massachusetts Weekly en PressRelease 2026-05-13T12:30:00+00:00 Vor Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/dde67700-b1b4-40c4-b930-13bd71804762/small/vor-wordmark-rgb-fullcolor-070920-png.png https://massachusettsweekly.com/article/912509747-excelsoft-technologies-achieves-50-60-faster-software-delivery-with-ai-sprints-coaching Massachusetts Weekly en PressRelease 2026-05-13T12:11:00+00:00 Excelsoft Technologies Achieves 50%–60% Faster Software Delivery With AI Sprints Coaching https://ml.globenewswire.com/media/64e66cfb-6b7a-4497-a917-76945f51a76f/small/aisprintslogo300dpi-png.png https://massachusettsweekly.com/article/912508626-candel-therapeutics-to-present-at-upcoming-investor-conferences Massachusetts Weekly en PressRelease 2026-05-13T12:05:00+00:00 Candel Therapeutics to Present at Upcoming Investor Conferences https://ml.globenewswire.com/media/8b82e1e3-4a67-4472-a7c8-05f9d24c9bb0/small/candel-logo-fullcolor-4-png.png https://massachusettsweekly.com/article/912508652-sionna-therapeutics-to-participate-in-the-2026-rbc-capital-markets-global-healthcare-conference Massachusetts Weekly en PressRelease 2026-05-13T12:00:00+00:00 Sionna Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference https://ml.globenewswire.com/media/0cda8c25-e758-4f0d-86f2-875df8411a9a/small/sionna-png.png https://massachusettsweekly.com/article/912508664-acronis-introduces-cyber-frame-addressing-service-provider-demand-for-profitable-reliable-and-protected-iaas Massachusetts Weekly en PressRelease 2026-05-13T12:00:00+00:00 Acronis Introduces Cyber Frame, Addressing Service Provider Demand for Profitable, Reliable, and Protected IaaS https://ml.globenewswire.com/media/7dfe00a6-5f9c-4761-a63e-daa24c010a4a/medium/acronis-cyber-frame.png https://massachusettsweekly.com/article/912508718-cerence-ai-to-participate-in-td-cowen-54th-annual-technology-media-telecom-conference Massachusetts Weekly en PressRelease 2026-05-13T12:00:00+00:00 Cerence AI to Participate in TD Cowen 54th Annual Technology, Media & Telecom Conference https://ml.globenewswire.com/media/873690ee-866c-4dea-9808-10aecc02890f/small/cerence-ai-logo-full-color-h-1-png.png https://massachusettsweekly.com/article/912508895-dyne-therapeutics-to-participate-in-upcoming-investor-conferences Massachusetts Weekly en PressRelease 2026-05-13T11:30:00+00:00 Dyne Therapeutics to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/2aa597a4-9b5c-4f0c-9ada-c5e06fa7d4de/small/dynelogo-r-final-full-color-rgb-jpg.jpg https://massachusettsweekly.com/article/912508944-pyxis-oncology-to-participate-in-upcoming-investor-conferences Massachusetts Weekly en PressRelease 2026-05-13T11:30:00+00:00 Pyxis Oncology to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/d3b77f06-3f52-42af-8f38-e3fda9c8025b/small/pyxis-logo-jpg.jpg https://massachusettsweekly.com/article/912509177-hengrui-pharma-and-kailera-therapeutics-announce-clinical-data-presentations-at-the-american-diabetes-association-86th-scientific-sessions Massachusetts Weekly en PressRelease 2026-05-13T11:30:00+00:00 Hengrui Pharma and Kailera Therapeutics Announce Clinical Data Presentations at the American Diabetes Association 86th Scientific Sessions https://ml.globenewswire.com/media/c0b33a3d-0c2b-45b0-ace8-6ff585b41339/small/kailera-logo-png.png https://massachusettsweekly.com/article/912509688-workable-launches-mcp-server-for-ai-powered-recruiting-and-hr-workflows Massachusetts Weekly en PressRelease 2026-05-13T11:21:14+00:00 Workable Launches MCP Server for AI-Powered Recruiting and HR Workflows https://ml.globenewswire.com/media/514c6a69-6edc-4085-9b6e-3fae732d70ba/medium/workable-launches-mcp-server.png https://massachusettsweekly.com/article/912508737-beam-therapeutics-to-present-at-2026-rbc-capital-markets-global-healthcare-conference Massachusetts Weekly en PressRelease 2026-05-13T11:00:00+00:00 Beam Therapeutics to Present at 2026 RBC Capital Markets Global Healthcare Conference https://ml.globenewswire.com/media/03af3276-c254-436a-b40d-2ad9a1025f95/small/beamlogo-color-cmyk-jpg.jpg https://massachusettsweekly.com/article/912508742-atea-pharmaceuticals-to-present-three-abstracts-at-easl-2026-congress-highlighting-progress-across-viral-hepatitis-pipeline Massachusetts Weekly en PressRelease 2026-05-13T11:00:00+00:00 Atea Pharmaceuticals to Present Three Abstracts at EASL 2026 Congress Highlighting Progress Across Viral Hepatitis Pipeline https://ml.globenewswire.com/media/1506ab30-7618-4ed0-98de-e3815adb3aa6/small/avir-png.png https://massachusettsweekly.com/article/912508907-corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences Massachusetts Weekly en PressRelease 2026-05-13T11:00:00+00:00 Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/459d6fb1-b336-4d47-8aa1-f9198bda891d/small/corbus-logo-jpg.jpg https://massachusettsweekly.com/article/912509297-upstream-bio-reports-first-quarter-2026-financial-results-and-recent-business-highlights Massachusetts Weekly en PressRelease 2026-05-13T11:00:00+00:00 Upstream Bio Reports First Quarter 2026 Financial Results and Recent Business Highlights https://ml.globenewswire.com/media/f1393297-d0b6-4706-960f-6128bcd0c6a4/small/upstream-logo-rgb-300x300px-jpg.jpg https://massachusettsweekly.com/article/912509105-zenas-biopharma-announces-first-subject-dosed-in-phase-1-clinical-trial-of-zb021-a-novel-potentially-best-in-class-oral-il-17aa-af-inhibitor Massachusetts Weekly en PressRelease 2026-05-13T10:50:00+00:00 Zenas BioPharma Announces First Subject Dosed in Phase 1 Clinical Trial of ZB021, a Novel, Potentially Best-in-Class Oral IL-17AA/AF Inhibitor https://ml.globenewswire.com/media/11a7c081-eaf9-4e1d-b413-227c20d8d41a/small/zenas-logo-jpg.jpg https://massachusettsweekly.com/article/912483877-voyager-asgct-late-breaker-single-iv-dose-of-vy1706-well-tolerated-reduced-tau-in-3-month-glp-toxicology-data-clinical-trial-in-alzheimer-s-disease Massachusetts Weekly en PressRelease 2026-05-13T10:01:00+00:00 Voyager ASGCT Late Breaker: Single IV Dose of VY1706 Well Tolerated, Reduced Tau in 3-Month GLP Toxicology Data; Clinical Trial in Alzheimer’s Disease Expected H2 2026 https://ml.globenewswire.com/media/f775f55a-83dd-4b38-bf92-bb9b588522bd/small/voyager-logos-square-logo-light-png.png https://massachusettsweekly.com/article/912483898-zenas-biopharma-reports-first-quarter-2026-financial-results-and-provides-corporate-update Massachusetts Weekly en PressRelease 2026-05-13T10:00:00+00:00 Zenas BioPharma Reports First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/11a7c081-eaf9-4e1d-b413-227c20d8d41a/small/zenas-logo-jpg.jpg https://massachusettsweekly.com/article/912464757-fortis-life-sciences-vergibt-den-abnano-vhh-discovery-grant-2026-an-deliver-biosciences-im-bereich-der-gezielten-wirkstoffabgabe Massachusetts Weekly en PressRelease 2026-05-13T06:20:00+00:00 Fortis Life Sciences vergibt den AbNano® VHH Discovery Grant 2026 an Deliver Biosciences im Bereich der gezielten Wirkstoffabgabe https://ml.globenewswire.com/media/35b82fbc-92f2-41d4-abbb-3a83618a33b7/small/fortis-logo-purple-png.png https://massachusettsweekly.com/article/912464760-fortis-life-sciences-attribue-la-subvention-la-d-couverte-abnano-vhh-discovery-2026-deliver-biosciences-pour-la-recherche-sur-l-administration Massachusetts Weekly en PressRelease 2026-05-13T06:20:00+00:00 Fortis Life Sciences attribue la subvention à la découverte AbNano® VHH Discovery 2026 à Deliver Biosciences pour la recherche sur l’administration ciblée de médicaments https://ml.globenewswire.com/media/35b82fbc-92f2-41d4-abbb-3a83618a33b7/small/fortis-logo-purple-png.png